seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - астма - Лекарства за обструктивна заболявания на дихателните пътища, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
sumetrolim 400 mg/80 mg tablets
egis pharmaceuticals plc, - Комбинация - 400 mg/80 mg tablets
sumetrolim 25 mg/ml + 5 mg/ml syrup
egis pharmaceuticals public limited company - Сулфаметоксазол и Триметоприм - 25 mg/ml + 5 mg/ml syrup
bropair spiromax
teva b.v. - xinafoate салметерол, флутиказона пропионат - астма - Лекарства за обструктивна заболявания на дихателните пътища, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
salmeterol/fluticasone genetic 25 microgram/250 microgram per metered dose pressurized inhalation, suspension
25 microgram/250 microgram per metered dose pressurized inhalation, suspension
salmeterol/fluticasone genetic 25 microgram/50 microgram per metered dose pressurized inhalation, suspension
25 microgram/50 microgram per metered dose pressurized inhalation, suspension
salmeterol/fluticasone genetic 25 microgram/125 microgram per metered dose pressurized inhalation, suspension
25 microgram/125 microgram per metered dose pressurized inhalation, suspension
sumetrolim 25 mg/ml + 5 mg/ml syrup
25 mg/ml + 5 mg/ml syrup
salmeterol and fluticasone cipla 25 micrograms/250 micrograms/dose pressurised inhalation, suspension
25 micrograms/250 micrograms/dose pressurised inhalation, suspension
salmeterol and fluticasone cipla 25 micrograms/125 micrograms/dose pressurised inhalation, suspension
25 micrograms/125 micrograms/dose pressurised inhalation, suspension